Drawing for FIGHTING CANCER EVERY STEP OF THE WAY

USPTO serial 86399923

FIGHTING CANCER EVERY STEP OF THE WAY

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
KHAN, AHSEN M
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with FIGHTING CANCER EVERY STEP OF THE WAY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Hoang-chi Truong

HOANG-CHI TRUONG PATENT LAW WORKS LLP310 East 4500 South, Suite 400SALT LAKE CITY, UT 84107UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic test kits comprised of medical diagnostic reagents used for screening and detecting diseases; diagnostic test kits comprised of medical diagnostic reagents used for screening and detecting cancerACTIVE—
042Providing medical and scientific research in the field of cancer; scientific research for medical purposes and analyses in the field of cancer; product research and development services; research, development, engineering, testing, and analytical services in the fields of vaccines, screening and detecting diseases, and medicine; research and development of vaccines, immunotherapies, and medical diagnostics kits; research and development of diagnostic test kits for screening and detecting diseases; laboratory research and testing services relating to vaccines, screening and detecting diseases, and medicine; consulting services in the fields of science and medicine, namely, consulting services relating to vaccine development and the development of methods for screening and detecting diseases; scientific and technological services and research and design relating thereto, namely, the development of vaccines, methods for screening and detecting diseases, and medicine; industrial analysis and research services, namely, industrial research in the field of development of vaccines, screening and detecting diseases, and medicine; computer services, namely, design and development of computer hardware and software; computer services, namely, software as a service (SAAS) services featuring software that provides information, test results for screening and detecting diseases, and the analysis, evaluation, and reporting of those test results to healthcare professionals and patientsACTIVE—
044Medical diagnostic services, namely, medical testing for diagnostic or treatment purposes; medical diagnostic services, namely, medical diagnostic testing, monitoring and reporting servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 18, 2018MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 18, 2018ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 21, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 21, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 20, 2017EX5GSOU EXTENSION 5 GRANTED—
Nov 20, 2017AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 13, 2017EXT5SOU EXTENSION 5 FILED—
Nov 13, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 13, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 11, 2017EX4GSOU EXTENSION 4 GRANTED—
May 11, 2017EXT4SOU EXTENSION 4 FILED—
May 11, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 6, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 3, 2016EX3GSOU EXTENSION 3 GRANTED—
Nov 9, 2016EXT3SOU EXTENSION 3 FILED—
Nov 9, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 19, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 16, 2016EX2GSOU EXTENSION 2 GRANTED—
Jun 24, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 12, 2016EXT2SOU EXTENSION 2 FILED—
May 12, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 8, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 7, 2015EX1GSOU EXTENSION 1 GRANTED—
Oct 6, 2015AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 1, 2015EXT1SOU EXTENSION 1 FILED—
Oct 1, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 12, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 17, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 17, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 25, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 9, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 7, 2015ALIEASSIGNED TO LIE—
Jan 21, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 20, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 19, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 19, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 22, 2014GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Dec 22, 2014GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Dec 22, 2014EPENCOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY—
Dec 22, 2014CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Dec 16, 2014DOCKASSIGNED TO EXAMINER—
Sep 26, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 23, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance